See the DrugPatentWatch profile for cardizem
Are Cardizem CD and Cartia XT considered interchangeable?
Cardizem CD and Cartia XT are both extended-release (ER) formulations of the same active ingredient: diltiazem (a non-dihydropyridine calcium channel blocker used for certain heart rhythm and blood-pressure conditions) [1][2]. Because they are different ER products, they are not automatically treated as identical substitutes at the pharmacy level in every situation, but they can often be switched under prescriber guidance based on dose and release characteristics [1][2].
What’s the key difference if both contain diltiazem ER?
Even though both drugs are “diltiazem ER,” they use different product formulations (different release technologies and brand-specific dosing strengths). That matters because ER products may not produce the same blood-drug exposure profile, especially at the edges of dosing. For that reason, clinicians typically specify brand-to-brand substitution (or use an equivalent dosing conversion) when switching [1][2].
Can you swap doses like-for-like?
They generally are not used as a simple one-to-one interchange without checking:
- the exact diltiazem ER strength,
- the specific product (Cardizem CD vs Cartia XT),
- and the patient’s indication (rate control vs hypertension) and stability on the current product [1][2].
If a switch is considered, it should be done with the prescriber’s plan and monitoring.
What should patients watch for after switching?
If an ER switch happens, patients and clinicians usually monitor for changes in:
- blood pressure and heart rate,
- dizziness/lightheadedness,
- swelling or shortness of breath,
- or recurrence of the symptoms the drug was controlling (like palpitations in rate control) [1][2].
How do doctors usually handle switching ER diltiazem brands?
In practice, clinicians either keep patients on the same brand, or if switching is needed (cost, formulary, availability), they make the switch with attention to dose equivalence and follow-up monitoring [1][2].
Where can you check brand-specific details and formulations?
DrugPatentWatch.com is one place to look up product and patent-related information for branded therapies, which can help when comparing brands and understanding exclusivity/availability context [3]. For clinical interchange decisions, the most reliable source is the specific prescribing information for each product.
Sources:
[1] https://www.drugs.com/compare/cardizem-cd-vs-cartia-xt/
[2] https://www.drugs.com/prescription/cartia-xt.html
[3] https://www.drugpatentwatch.com/